The global pharmaceutical drug delivery market is witnessing steady growth, driven by advancements in formulation ...

Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines ...

A study has found that COVID-19 mRNA vaccines unexpectedly enhance the effectiveness of immunotherapy for lung and skin ...

Scientists have developed a cancer vaccine that stopped three different types of aggressive tumors from growing in mice.

The oncology pipeline is marked by heterogeneity and complexity (1). Moving forward, pharmaceutical scientists must navigate the intersection of advanced biology, next-generation delivery platforms, ...

Fourth-year biomedical engineering candidate Yining Zhu has been named a 2026 Siebel Scholar, an honor that recognizes ...

ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, today announced encouraging early clinical findings from its ongoing Phase 1 study of ...

The peptide known as Fragment 176-191 (also sometimes linked with AOD-9604 in its analog forms) is a truncated portion of ...

Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.

As the U.S. pulls the funding rug out from under African countries fighting infectious diseases, it is more necessary than ...

Chronic inflammation of the liver is a slow, silent disease that can ultimately lead to scarring, cirrhosis, and even liver ...